Well, I was right that Affymetrix
Yesterday, the Rule Breakers pick and biochip maker announced that it was purchasing laboratory-reagent maker USB for about $75 million in cash. The privately held USB makes enzymes and molecular purification systems that compete with the likes of Invitrogen
Frankly, I'm a little surprised at the move. I thought Affymetrix was going to let rival Illumina
But I still think that Affymetrix should concentrate on its diagnostics business. Given Roche's repeated attempts to purchase Ventana Medical Systems
More Foolishness on lab supply companies:
- Drugmaker Growth Without the FDA
- More Drugmaker Growth Without the FDA
- The 2 Sides of Bio-Rad
- A Guide to Innovative Technology
Help us in our goal to give every young person around the globe a financial education. Learn more about the new direction of Foolanthropy, now in its second decade, here.